Clinical Alarm Management Market Overview, Regional Analysis and Forecast 2023 to 2033

From 2023 to 2033, the global Clinical Alarm Management Market sales is anticipated to be valued US$ 6.2 billion, increasing at a 7.5% CAGR. Alarms are used to alert personnel when a situation is hazardous or life-threatening and demands immediate action. Alarms, on the other hand, regularly sound even when there is no such scenario, leading to alarm fatigue. The vast majority of non-urgent warnings do not require immediate staff action.

A persistent stream of nuisance messages causes alarm fatigue, which results in slow or no response, muting or silencing alarms, or turning off the alarm entirely. This causes background noise in the unit's vicinity. If the alarm is muted or turned off, staff may not be notified of an emergency.

Although there are strategies to lessen alarm fatigue, none of them can completely solve the problem. A variety of mitigating actions are necessary, some of which may need to be customised for the unit or patient. warning parameters, for example, can be adjusted as needed to increase the likelihood that the warning will only sound when the patient genuinely need care.

In some cases, it may be able to add a small delay to the alarm, allowing things to self-correct after a few seconds. Another option is to pay technicians to inspect patient monitors and warn staff of any problems. This page goes into greater detail about these interventions.

Key Players Operating in the Global Market include

  • Medtronic
  • GE Healthcare
  • Koninklijke
  • Philips N. V.
  • Baxter
  • Connexall
  • Mindray Medical International Limited
  • Vocera
  • Drager
  • Spok Inc

Read More Details@ https://www.futuremarketinsights.com/reports/clinical-alarm-management-market

Key Segment

By Component:

  • Solution
    • Clinical Decision Support Tool
    • Central Monitoring System
    • Mobility Solution
    • Clinical Alarm Reporting Software
    • Alarm Auditing Software
  • Service
    • Consulting
    • Implementation and Integration
    • Monitoring and Analytics

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Long-term and Palliative Care Centers
  • Home Care
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more